Showing 1 - 1 results of 1 for search 'Richeng Jiang', query time: 0.01s Refine Results
  1. 1
    Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis

    Osimertinib plus anlotinib for advanced NSCLC with acquired EGFR T790M mutation: results from a multicenter phase II study with ctDNA analysis by Xinyue Wang, Zhaona Li, Liuchun Wang, Yan Liang, Chun Huang, Peng Chen, Dingzhi Huang, Xia Song, Cuimin Ding, Changli Wang, Richeng Jiang

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: